Alain C. Jung

2.0k total citations
46 papers, 1.6k citations indexed

About

Alain C. Jung is a scholar working on Molecular Biology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Alain C. Jung has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Oncology and 13 papers in Otorhinolaryngology. Recurrent topics in Alain C. Jung's work include Head and Neck Cancer Studies (13 papers), RNA modifications and cancer (6 papers) and Invertebrate Immune Response Mechanisms (5 papers). Alain C. Jung is often cited by papers focused on Head and Neck Cancer Studies (13 papers), RNA modifications and cancer (6 papers) and Invertebrate Immune Response Mechanisms (5 papers). Alain C. Jung collaborates with scholars based in France, United States and Switzerland. Alain C. Jung's co-authors include Dominique Ferrandon, Sophie Rutschmann, Jules A. Hoffmann, Bohdan Wasylyk, Joseph Abecassis, Charles Hétru, Jean‐Marc Reichhart, Neal Silverman, Rui Zhou and Markus Affolter and has published in prestigious journals such as Immunity, Nature Immunology and PLoS ONE.

In The Last Decade

Alain C. Jung

45 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain C. Jung France 22 614 594 354 297 281 46 1.6k
André L. Vettore Brazil 24 280 0.5× 1.1k 1.9× 332 0.9× 168 0.6× 68 0.2× 53 1.8k
Susmita Ghosh United States 20 90 0.1× 429 0.7× 150 0.4× 31 0.1× 45 0.2× 59 895
Jihye Cha South Korea 15 32 0.1× 1.4k 2.4× 221 0.6× 79 0.3× 39 0.1× 35 2.0k
Dion Kaiserman Australia 21 558 0.9× 498 0.8× 167 0.5× 37 0.1× 6 0.0× 36 1.2k
Francesca Belleudi Italy 28 344 0.6× 1.1k 1.9× 352 1.0× 5 0.0× 10 0.0× 59 1.7k
Charlotte M. Fryling United States 12 386 0.6× 875 1.5× 385 1.1× 7 0.0× 10 0.0× 14 1.5k
Alan J. Halperin United States 10 136 0.2× 1.1k 1.9× 1.0k 2.8× 31 0.1× 6 0.0× 13 2.4k
Eudoxia Hatzivassiliou Greece 13 784 1.3× 867 1.5× 875 2.5× 41 0.1× 2 0.0× 23 2.0k

Countries citing papers authored by Alain C. Jung

Since Specialization
Citations

This map shows the geographic impact of Alain C. Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain C. Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain C. Jung more than expected).

Fields of papers citing papers by Alain C. Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain C. Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain C. Jung. The network helps show where Alain C. Jung may publish in the future.

Co-authorship network of co-authors of Alain C. Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Alain C. Jung. A scholar is included among the top collaborators of Alain C. Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain C. Jung. Alain C. Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Martı́nez-Alonso, Marta, Albert Gandioso, Xue Qin, et al.. (2023). A Novel Near‐IR Absorbing Ruthenium(II) Complex as Photosensitizer for Photodynamic Therapy and its Cetuximab Bioconjugates. ChemBioChem. 24(15). e202300203–e202300203. 15 indexed citations
4.
Foppolo, Sophie, S. Guihard, Romain Vauchelles, et al.. (2023). Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids. International Journal of Molecular Sciences. 24(13). 11178–11178. 4 indexed citations
5.
Wasylyk, Bohdan, et al.. (2023). The Multifaceted Role of Human Dickkopf-3 (DKK-3) in Development, Immune Modulation and Cancer. Cells. 13(1). 75–75. 9 indexed citations
6.
Schultz, Philippe, Christian Borel, Erwan Pencreach, et al.. (2022). The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response. Cells. 11(18). 2866–2866. 6 indexed citations
7.
Foppolo, Sophie, Véronique Bruban, Nelly Étienne-Selloum, et al.. (2021). Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma. Cancers. 13(12). 3038–3038. 9 indexed citations
8.
9.
Cristea, Mihaela, Paul Frankel, Timothy W. Synold, et al.. (2020). 863P A phase I study of mirvetuximab soravtansine (MIRV) and gemcitabine (G) in pts with selected FRα -positive solid tumours: Results in the endometrial cancer (EC) cohort. Annals of Oncology. 31. S639–S639. 1 indexed citations
10.
Job, Sylvie, Aurélien de Reyniès, Amélie Weiss, et al.. (2019). Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction. Cancers. 11(6). 795–795. 16 indexed citations
11.
Mirghani, H., Alain C. Jung, & Carole Fakhry. (2017). Primary, secondary and tertiary prevention of human papillomavirus-driven head and neck cancers. European Journal of Cancer. 78. 105–115. 12 indexed citations
12.
Job, Sylvie, Christine Wasylyk, Erwan Pencreach, et al.. (2015). Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature. Oral Oncology. 51(9). 848–856. 26 indexed citations
13.
Wasylyk, Christine, et al.. (2014). The Oncogenic MicroRNA Hsa-miR-155-5p Targets the Transcription Factor ELK3 and Links It to the Hypoxia Response. PLoS ONE. 9(11). e113050–e113050. 35 indexed citations
14.
Jung, Alain C., et al.. (2013). A Poor Prognosis Subtype of HNSCC Is Consistently Observed across Methylome, Transcriptome, and miRNome Analysis. Clinical Cancer Research. 19(15). 4174–4184. 43 indexed citations
15.
Klotz, Rémi, Sophie Pinel, Claire Barbieux, et al.. (2013). DDB2: A Novel Regulator of NF-κB and Breast Tumor Invasion. Cancer Research. 73(16). 5040–5052. 39 indexed citations
16.
Wasylyk, Bohdan, Joseph Abecassis, & Alain C. Jung. (2013). Identification of clinically relevant HPV-related HNSCC: In p16 should we trust?. Oral Oncology. 49(10). e33–e37. 31 indexed citations
17.
Guihard, S., et al.. (2012). The NEDD8 conjugation pathway regulates p53 transcriptional activity and head and neck cancer cell sensitivity to ionizing radiation. International Journal of Oncology. 41(4). 1531–1540. 23 indexed citations
18.
Jung, Alain C., Barry Denholm, Helen Skaer, & Markus Affolter. (2005). Renal Tubule Development in Drosophila. Journal of the American Society of Nephrology. 16(2). 322–328. 63 indexed citations
19.
Rutschmann, Sophie, Alain C. Jung, Rui Zhou, et al.. (2000). Role of Drosophila IKKγ in a Toll-independent antibacterial immune response. Nature Immunology. 1(4). 342–347. 222 indexed citations
20.
Rutschmann, Sophie, Alain C. Jung, Charles Hétru, et al.. (2000). The Rel Protein DIF Mediates the Antifungal but Not the Antibacterial Host Defense in Drosophila. Immunity. 12(5). 569–580. 291 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026